CLINUVEL PHARMACEUTICALS (CUV) Shares
ABOUT CLINUVEL PHARMACEUTICALS
Clinuvel Pharmaceuticals Group is a global biopharmaceutical company which focuses on developing drugs for the treatment of a range of severe skin disorders. The Group has a history dating back to 1987 when university researchers launched an idea for synthesizing human hormones to protect the skin.
In 2001 the company obtained the rights to the technologies and established itself around alpha-MSH, its derivatives and knowledge.
The company went on to develop innovative technology which would release the hormonal analogue in picograms (10¯¹² grams) per day in a controlled fashion, which was tested in more than 1 400 patients worldwide through 4 500 doses.
The company’s SCENESSE product became the first systemic drug providing protection to the entire skin surface without exposure to light and UV.
OVERVIEW OF CLINUVEL PHARMACEUTICALS
Clinuvel Pharmaceuticals Group works to translate scientific breakthroughs into commercial products. To this end, the Group creates, develops, and advances products which are driven by medical need, consumer demand or lack of available solutions. Its technologies aim to add value beyond existing offerings.
The company’s primary offering in its portfolio is its SCENESSE product, which is its proprietary first-in-class photo-protective drug. The drug has been approved for marketing authorization under exceptional circumstances by the European Medicines Agency for the prevention of photo-toxicity in adults with the orphan disease erythropoietic protoporphyria (EPP).
In October 2019 the US Food & Drug Administration (FDA) granted marketing approval to use SCENESSE for the treatment of EPP patients in the United States.
VISION & VALUES OF CLINUVEL PHARMACEUTICALS
As a socially responsible pharmaceutical company and part of the global community, Clinuvel Pharmaceuticals is highly conscious of its accountability for the management and governance of environmental and social issues. The Group maintains an ongoing focus on energy conservation, waste minimization and safe materials handling.
The Group highly values integrity and honesty. For each decision the Group makes it requires a justification and rationale which takes into account expected behaviour throughout the Group of companies. The Group’s focus on ethics extends to research and development as a pharmaceutical company which develops and distributes treatments for indications with unmet medical need.
It consistently applies industry best practice standards for the conduct of research and development, and studies involving non-human and human subjects. When necessary to obtain regulatory approvals of treatments, the Group actively seeks to minimize the extent of these studies.
MARKET PERFORMANCE OF CLINUVEL PHARMACEUTICALS
Clinuvel Pharmaceuticals Group trades on the Australian Securities Exchange (ASX), where investors can buy shares under the stock symbol -CUV.
Data from the Group’s 2019 financial analysis shows US Dollar 18.115 million profit before tax, compared to US Dollar 12.942 million for the prior financial year, a 39.96% increase and the highest before tax profit result in the Group’s history.
This result reinforces the Group’s primary strategic focus during the year to maintain and progress the commercial rollout of SCENESSE in the EU whilst the US FDA reviews the Group’s NDA to make SCENESSE available in the US for EPP patients.
The Group achieved Total Revenues of US Dollar 31,048 million in the year ended 30 June 2019, a 22% increase on the prior year to 30 June 2018. This strong operational performance has delivered a flourishing share price for investors with good long-term growth in dividends, securing a solid buy-in for investors who choose to purchase shares.
Buy CLINUVEL PHARMACEUTICALS stocks / shares – A Step by Step Guide how to Buy / Purchase CLINUVEL PHARMACEUTICALS Stocks or Shares online.
Before buying any stock or share one has to consider a few factors.
STEP 1: PROPER RESEARCH IS ESSENTIAL
Upon deciding you want to buy CLINUVEL PHARMACEUTICALS Stocks / Shares, it is critical for the serious investor to do proper research into the said company. Its values should align with those of the investor’s current portfolio. An investor needs to familiarise himself with the basics and history of the company, as well as its leadership and performance in the market. Its company reports should also be scrutinized.
Consultation with a brokerage firm can also assist in determining whether investing in a specific company will complement the investor’s current portfolio. The investment “risk ladder”, which identifies asset classes based on their relative riskiness, is another useful tool when determining which company’s stock / share is the best to buy.
STEP 2: CALCULATE THE AMOUNT OF INVESTMENT IN CLINUVEL PHARMACEUTICALS STOCKS / SHARES
It is important for an investor to monitor his total investment in stock in order to keep his portfolio aligned to his investment strategy. The overall value of his holdings will change with the fluctuation in stock prices, which can throw his portfolio off balance. To determine the amount to invest, multiply the number of shares of each stock by its current market price to determine the total investment in that specific stock. For example, if you own 100 shares of a US Dollar 5 stock, multiply 100 by US Dollar 5 to get US Dollar 500.
STEP 3: DECIDE ON THE STOCK / SHARE ORDER TYPE
Investors can choose from a market order, a limit order, a stop order (also referred to as a stop-loss order) or a buy/sell stop order. It is important to familiarise yourself with each type’s pros and cons before deciding which one will suit your current stock profile best. An investor should be guided in this choice by his investment objective.
STEP 4: OPEN A BROKERAGE ACCOUNT
A brokerage account – also known as taxable investment account – is similar to a retirement account, but more flexible. Where a retirement account has limitations on the amount of money that can be contributed annually, and restrictions on when funds can be withdrawn, a brokerage account is more flexible. The latter has no income or contribution limit and the investor can withdraw his money at any given time. This flexibility, together with its potential investment gains, makes a brokerage account more attractive to serious investors. Brokerage accounts are ideal for goals or savings that are further than five years away, but closer than retirement. It can also supplement an investor’s emergency savings.
STEP 5: COMMIT AND PURCHASE CLINUVEL PHARMACEUTICALS STOCKS / SHARES
Lastly, commit to the stock. Pro Tip: Monitor the value of your stock to ensure you have a growing stock value and dividend pay-out. Regularly check the share price online to ensure your investment delivers a positive return on investment. You are now a proud owner of CLINUVEL PHARMACEUTICALS stocks / shares.
5 Questions to ask yourself before purchasing any stocks or shares.
- Is it the best time to buy this stock / share?
- Should I buy CLINUVEL PHARMACEUTICALS stocks / shares in the current economic climate?
- Can I afford to buy this stock / share?
- What is the forecast of the stock / share growth?
- What is the current price per earning ration on the stock / share?